Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy
Harvard University · Massachusetts General Hospital · +4 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
938
total citations
- FWCI
- 45.43
- Percentile
- 100%
- References
- 45
Citations per year
Authors
21- CPChristina PfirschkeCorresponding
Harvard University, Massachusetts General Hospital, Center for Systems Biology
- CECamilla Engblom
Harvard University, Massachusetts General Hospital, Center for Systems Biology
- SRSteffen Rickelt
Massachusetts Institute of Technology
- VCVirna Cortez‐Retamozo
Harvard University, Massachusetts General Hospital, Center for Systems Biology
- CGChristopher Garris
Harvard University, Massachusetts General Hospital, Center for Systems Biology
Topics & keywords
Topics
Keywords
- Blockade
- Biology
- Cancer research
- Chemotherapy
- Immunology
- Receptor
- Biochemistry
- Genetics
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.